|Day Low/High||115.00 / 116.30|
|52 Wk Low/High||81.49 / 132.13|
U.S. stocks retreat into the red as a number of positive and negative earnings reports keep trading choppy.
This is the group that is the most dangerous politically.
Our quantitative service has upgraded the drug maker to a buy, but the technicals are not ready yet to join in.
FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.
U.S. stocks lose earlier highs on Tuesday as the health care sector pulls the markets lower.
Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.
Eli Lilly earnings came in short by 2 cents but revenue was slightly higher than estimates.
TheStreet's Jim Cramer isn't too fond of the pharmaceutical sector and he doesn't see that changing anytime soon.
TheStreet's Jim Cramer is on the floor of the NYSE talking MLB's Opening Day and answering social media questions.
Consider the LLY out-of-the-money, bearishly biased vertical put spread expiring in May.
TheStreet's Jim Cramer is concerned about what Eli Lilly has in its pipeline of new prospects.
TheStreet's Jim Cramer says Gilead (GILD) needs to make an acquisition to jump start its business.
Closing this trade now as gains are sweet and should be locked in.
TheStreet’s Jim Cramer commented on United Airlines and JetBlue on Tuesday from the floor of the New York Stock Exchange.
Jim Cramer says healthcare companies will be in the spotlight this week and investors should take a long term view of the sector if the stocks selloff.
In 'What's Ahead on Wall Street' for Thursday January 28, there are lots of earnings on tap but TheStreet highlights a few major ones.
Two significant, but subtle forces may threaten the group in the next 12 months.
Lack of volume is causing the exaggerated market moves, right now.
Sky-high drug prices and rising insurance premiums are grabbing the daily headlines.
U.S. stocks returned to positive territory in Tuesday's trading session after Monday's steep selloff.
Jim Cramer made some predictions about the stock market in 2016 while answering viewers’ social media questions.
General Mills (GIS) is a still a stock to hold for the long term, even as the company missed on earnings due to a slump in cereal sales, says Cramer.
Jim Cramer, portfolio manager of TheStreet’s Action Alerts PLUS and host of CNBC’s ‘Mad Money,’ talked about how to play defense in a down market on Friday.